Biologic Videos

  1. Cytovance Biologics Capacity Update April 2025: Large Molecule Development 4/22/2025

    Speed up your program with end-to-end microbial and mammalian biologics development and manufacturing expertise — spanning everything from biosimilars to vaccines.

  2. Novartis Capacity Update April 2025: Large Molecule Development 4/22/2025

    Experience a global network of expertise and proven manufacturing capabilities that can help accelerate your clinical and commercial drug substance programs.

  3. Samsung Biologics Capacity Update April 2025: Large Molecule Development 4/22/2025

    Leveraging advanced technology, expertise, and flexible capacity, clients can reduce development time and costs while ensuring a smooth transition from clinical to commercial manufacturing.

  4. Boehringer Ingelheim Capacity Update April 2025: Large Molecule Development 4/22/2025

    Explore how world-class contract manufacturing expertise and global capabilities can help accelerate your biologic from development to commercial success.

  5. Catalent Capacity Update April 2025: Large Molecule Development 4/22/2025

    By leveraging our proprietary non-viral gene insertion technology, GPEx® Lightning ensures rapid development timelines and high-yield production, making it an ideal solution for complex biologics.

  6. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Large Molecule Development 4/22/2025

    Associate Director kojoX and Technology Development, Rasmus Petersen, presents a high-level overview of FDB’s capabilities, its global facilities network, and capacity updates for BIOLOGICS.

  7. AGC Biologics Capacity Update April 2025: ADC 4/21/2025

    This presentation offers a global overview of our comprehensive ADC program, providing developers with full end-to-end support — all under a single, streamlined contract.

  8. Simtra Biopharma Solutions Capacity Update April 2025: ADC 4/21/2025

    Witness how proven expertise and expanding capabilities in ADC manufacturing can help you scale high-value injectable therapies with speed, quality, and regulatory confidence.

  9. Abzena Capacity Update April 2025: ADC 4/21/2025

    Our integrated expertise can help you develop and manufacture dual payload ADCs with optimized efficacy, precision conjugation, and scalable solutions.

  10. Aragen Bioscience, Inc. Capacity Update April 2025: ADC 4/21/2025

    Discover how our end-to-end ADC solutions — from advanced conjugation technologies to scalable manufacturing — can accelerate your therapeutic development.